[5-aminosalicylic acid treatment of ulcerative colitis during the acute phase in patients resistant or intolerant to salazopyrine].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D004338:Drug Combinations / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology; D004342:Drug Hypersensitivity / Q000209:etiology*; D004361:Drug Tolerance; D005260:Female; D005944:Glucosamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D019804:Mesalamine; D008875:Middle Aged; D012460:Sulfasalazine / Q000009:adverse effects*
D000636:Aminosalicylic Acids; D004338:Drug Combinations; C028423:Salazopyrine; D012460:Sulfasalazine; D019804:Mesalamine; D005944:Glucosamine
Trattamento con acido 5-aminosalicilico della colite ulcerosa in fase acuta in fase acuta in pazienti resistenti o intolleranti alla salazopirina.